Methods and pharmaceutical compositions for the treatment of chronic kidney disease

The present invention relates to methods and pharmaceutical compositions for the treatment of chronic kidney disease. The inventors used the CMap resources to identify the sesquiterpene lactone parthenolide that was subsequently analyzed for its in vivo capacity to reduce the development of DKD in the type I diabetes mouse model.In particular, the invention relates to a method of treating chronic kidney disease (CKD) in patient in need thereof comprising administering to the patient a therapeutically effective amount of Dimethylaminoparthenolide (DMAPT).

Publications:
Sci Rep. 2020 Sep 10;10(1):14898. doi: 10.1038/s41598-020-71950-7.

Reference:

BIO20193-T1

Business Developper
contact
Aymeric Empereur
Aymeric Empereur
Business Developer

You might also be interested in